-
Symbol
-
CTMX on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.00001 par value per share
-
Latest Disclosed Shares Owned
-
15,561,500 shares
-
Security Ownership %
-
9.4%
Venrock Healthcare Capital Partners III, L.P. ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)
14 Nov 2025 - Venrock Healthcare Capital Partners III, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 15,561,500 shares of CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX).
This represents 9.4% ownership of the company.
In their previous filing dated 20 May 2025, Venrock Healthcare Capital Partners III, L.P. had reported owning 12,992,500 shares, indicating an increase of +20%.
.